Treatment of tardive dystonia with an antispastic agent

Acta Psychiatrica Scandinavica

Volumn 98, Issue 4, 1998, Pages 341-343

  Nisijima, K ^a   Shimizu, M ^a   Ishiguro, T ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antispastic agents; Eperisone; Tardive dystonia; Tolperisone

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; EPERISONE; HALOPERIDOL; NEUROLEPTIC AGENT; PIPAMPERONE; RISPERIDONE; SPASMOLYTIC AGENT; TETRABENAZINE; TOLPERISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DYSTONIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0031787659     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1998.tb10094.x     Document Type: Article

References (15)

1. BURKE RE, FAHN S, JANKOVIC J et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982: 32: 1335-1346.
2. NOVALES-LI P, SUN XP, TAKEUTCHI H. Suppression of calcium current in a snail neurone by eperisone and its analogues. Eur J Pharmacology 1989: 168: 299-305.
3. COWARD DM, WHITE TG. Comparison of the myotonolytic activity of tizanidine, eperisone and afloqualone in mouse and rabbit. J Intern Med Res 1989: 17: 358-362.
4. PRATZEL HG, ALKEN RG, RAMM S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain 1996: 67: 417-425.
5. OWENS DJ, JOHNSTONE EC, FRITH CD. Spontaneous involuntary disorders of movement: their prevalence, severity and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry 1982: 39: 452-461.
6. WOJCIK JD, FALK WE, FINK JS, COLE JO, GELENBERG AJ. A review of 32 cases of tardive dystonia. Am J Psychiatry 1991: 148: 1055-1059.
7. ROSSE RB, ALLEN A, LUX WE. Baclofen treatment in a patient with tardive dystonia. J Clin Psychiatry 1986: 47: 474-475.
8. SHAPLESKE J, MCKAY AP, MCKENNA PJ. Successful treatment of tardive dystonia with clozapine and clonazepam. Br J Psychiatry 1996: 168: 516-518.
9. LUCHINS D, GOLDMAN M. High-dose bromocriptine in a case of tardive dystonia. Biol Psychiatry 1985: 20: 179-181.
10. ADITYANJEE, JAYASWAL SK, CHAN TM, SUBRAMANIAN M. Temporary remission of tardive dystonia following electroconvulsive therapy. Br J Psychiatry 1990: 156: 433-435.
11. TANAKA K, KANEKO T, YAMATSU K. Effects of 4′-ethyl-2-methyl-3-piperidinopropiophenone on experimental rigidity and spinal cord activities. Folia Pharmacol Jap 1981: 77: 511-520.
12. ISHIZUKI M, YANAGISAWA MA. Antinociceptive effects of tizanidine, diazepam and eperisone in isolated spinal cordtail preparations of newborn rat. Pain 1992: 48: 101-106.
13. FUJITA T, TAKAMATSU T, HISAMOTO T, TSUTSUMI J, KINOSHITA K, KANAI T. Studies on the metabolic fate of 4′-ethyl-2-methyl-3-piperidinopropiophenone hydrochloride (1): absorption, distribution and excretion in rats and guinea pigs. Pharmacometrics 1981: 21: 835-846.
14. HASEGAWA Y, KAKU S, ARAKI H, OTOMO S. Sigma receptor modulation of the muscle relaxant action of eperisone. Eur Neuropharmacology 1992: 2: 157-159.
15. WALKER JM, MATSUMOTO RR, BOWEN WD, GANS DL, JONES KD, WALKER FO. Evidence for a role of haloperidol sensitive σ-'opiate' receptors in the motor effects of antipsychotic drugs. Neurology 1988: 38: 961-965.